LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit
LifeMD (Nasdaq: LFMD) will participate in the Truist Securities Healthcare Disruptors & Digital Health Summit on June 25-26, 2024, at the Lotte New York Palace, New York City.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LifeMD (Nasdaq: LFMD) will participate in the Truist Securities Healthcare Disruptors & Digital Health Summit on June 25-26, 2024, at the Lotte New York Palace, New York City. CEO Justin Schreiber will join a panel discussion on “Weight Management/Diabetes Care: Tools to Manage Cost vs Benefit.” Additionally, LifeMD management will hold one-on-one meetings with institutional investors. Interested investors should contact their Truist Securities representative for more details.
Positive
- LifeMD's participation in the high-profile Truist Securities Healthcare Disruptors & Digital Health Summit may enhance its visibility among key industry stakeholders and investors.
- CEO Justin Schreiber's involvement in a panel discussion on weight management and diabetes care underlines the company's commitment to addressing critical health issues.
- One-on-one meetings with institutional investors during the summit offer potential opportunities for new investments and partnerships.
Negative
- No specific new product launches, financial updates, or significant business developments were announced in the press release.
- The press release does not provide any performance metrics or recent accomplishments, which may leave investors seeking more concrete information.
Details
News Market Reaction – LFMD
The recorded move for LFMD in the trading session of this news was +0.27%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the Truist Securities Healthcare Disruptors & Digital Health Summit taking place June 25-26, 2024 at the Lotte New York Palace. Justin Schreiber, Chief Executive Officer of LifeMD, will be joining a panel discussion titled “Weight Management/Diabetes Care: Tools to Manage Cost vs Benefit.” Management will also be holding one-on-one meetings with investors.
Institutional investors interested in attending the conference and meeting with LifeMD management should contact their Truist Securities representative.
About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women's health, weight management, and hormone therapy. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.